1
/
of
1
Elabscience
SKU:PKSR030273
Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active)
Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active)
Regular price
$732.00 USD
Regular price
Sale price
$732.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active), a cutting-edge product meticulously designed to cater to the diverse needs of the scientific community. This protein, derived from recombinant rat sources, boasts an exceptional level of purity and activity, ensuring optimal performance in a wide range of applications.
The Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active) is engineered with a His Tag, enabling facile purification and subsequent identification. This feature not only expedites the purification process but also facilitates downstream applications, saving valuable time and resources.
With its active nature, this protein exhibits remarkable functionality, making it an invaluable tool for various research endeavors. Its active form ensures accurate and reliable results, enabling scientists to delve deeper into the intricacies of CD172a/SIRPA protein interactions and associated biological processes.
Furthermore, the Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active) is manufactured with utmost precision and quality control measures, guaranteeing batch-to-batch consistency and reproducibility. This ensures that researchers can confidently rely on this product for their experiments, eliminating any concerns regarding variability.
The versatility of this protein is truly remarkable, as it can be employed in a multitude of applications, including but not limited to protein-protein interaction studies, receptor-ligand binding assays, and functional assays. Its broad applicability makes it an indispensable asset for scientists across various disciplines, ranging from immunology to cell biology.
In summary, the Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active) stands as a pinnacle of scientific innovation, offering researchers an exceptional tool to unravel the complexities of CD172a/SIRPA protein biology. With its unparalleled purity, activity, and versatility, this product is poised to revolutionize the field of molecular research, empowering scientists to make groundbreaking discoveries and advancements.
The Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active) is engineered with a His Tag, enabling facile purification and subsequent identification. This feature not only expedites the purification process but also facilitates downstream applications, saving valuable time and resources.
With its active nature, this protein exhibits remarkable functionality, making it an invaluable tool for various research endeavors. Its active form ensures accurate and reliable results, enabling scientists to delve deeper into the intricacies of CD172a/SIRPA protein interactions and associated biological processes.
Furthermore, the Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active) is manufactured with utmost precision and quality control measures, guaranteeing batch-to-batch consistency and reproducibility. This ensures that researchers can confidently rely on this product for their experiments, eliminating any concerns regarding variability.
The versatility of this protein is truly remarkable, as it can be employed in a multitude of applications, including but not limited to protein-protein interaction studies, receptor-ligand binding assays, and functional assays. Its broad applicability makes it an indispensable asset for scientists across various disciplines, ranging from immunology to cell biology.
In summary, the Recombinant Rat CD172a/SIRPA Protein (His Tag)(Active) stands as a pinnacle of scientific innovation, offering researchers an exceptional tool to unravel the complexities of CD172a/SIRPA protein biology. With its unparalleled purity, activity, and versatility, this product is poised to revolutionize the field of molecular research, empowering scientists to make groundbreaking discoveries and advancements.
Share
